Info

Enzon Pharmaceuticals, Inc. (Enzon) is a biopharmaceutical company focused on the development, manufacturing and commercialization of medicines for patients with cancer and other life-threatening conditions. The Company has a portfolio of four marketed products: Oncaspar, DepoCyt, Abelcet and Adagen. Enzon’s drug development programs utilize several approaches, including its PEGylation technology platform. The PEGylation technology was used to develop two of Enzon’s products, Oncaspar and Adagen, and has created a royalty revenue stream from licensing partnerships for other products developed using the technology. The Company is also engaged in contract manufacturing for several pharmaceutical companies. The Company operates in three business segments: Products, Royalties and Contract Manufacturing.(Source: 10-K)